Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109


A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis.

May M, Brookman-May S, Burger M, Koch S, Otto W, Bründl J, Albrecht K, Denzinger S.

Pathol Res Pract. 2015 May 28. pii: S0344-0338(15)00101-6. doi: 10.1016/j.prp.2015.05.007. [Epub ahead of print]


Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9].

Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF.

Eur Urol. 2015 Jul;68(1):171. doi: 10.1016/j.eururo.2015.02.007. Epub 2015 Feb 18. No abstract available.


[Anamnesis, Pathological Assessment, Therapeutic Features and Course of Disease: Retrospective Study on Clinical-Based Factors for Prediction of Cancer-Specific Survival of 378 Patients with Stage pT1 Urothelial Bladder Carcinoma].

Breyer J, Otto W, Hartmann A, Bumes B, Bründl J, Gierth M, Bertz S, Denzinger S, Burger M, Lausenmeyer EM.

Aktuelle Urol. 2015 May;46(3):221-6. doi: 10.1055/s-0035-1549905. Epub 2015 Jun 12. German.


Management of rectourinary fistula after urological interventions using biodesigned mesh: first experiences of an innovative technique.

Gierth M, Denzinger S, Liebig-Hörl G, Burger M, Fürst A.

Int J Colorectal Dis. 2015 May 28. [Epub ahead of print]


Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancer.

Rubenwolf P, Thomas C, Denzinger S, Hartmann A, Burger M, Georgopoulos NT, Otto W.

World J Urol. 2015 May 5. [Epub ahead of print]


Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.

Gierth M, Mayr R, Aziz A, Krieger S, Wullich B, Pycha A, Lodde M, Salvadori U, Bründl J, Fritsche HM, Hofstädter F, Pawlik MT, Otto W, May M, Burger M, Denzinger S.

J Cancer Res Clin Oncol. 2015 Apr 2. [Epub ahead of print]


[Urethral condylomata acuminata].

Brummeisl W, Lausenmeyer E, Weber F, Bründl J, Fritsche HM, Burger M, Denzinger S.

Urologe A. 2015 Mar;54(3):378-84. doi: 10.1007/s00120-014-3619-9. German.


Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients.

Breyer J, Denzinger S, Otto W, Bründl J, Gierth M, Fritsche HM, Rößler W, Wieland WF, Giedl C, Hofstädter F, Rubenwolf P, Burger M, Aziz A.

Urol Int. 2014;93(3):311-9. doi: 10.1159/000360483. Epub 2014 Sep 4.


Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.

Aziz A, Madersbacher S, Otto W, Mayr R, Comploj E, Pycha A, Denzinger S, Fritsche HM, Burger M, Gierth M.

Urol Int. 2015;94(1):37-44. doi: 10.1159/000363334. Epub 2014 Aug 13.


The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.

Mayr R, May M, Burger M, Martini T, Pycha A, Dechet C, Lodde M, Comploj E, Wieland WF, Denzinger S, Otto W, Aziz A, Fritsche HM, Gierth M.

Urol Int. 2014;93(3):303-10. doi: 10.1159/000362421. Epub 2014 Aug 19.


Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.

Aziz A, Rink M, Gakis G, Kluth LA, Dechet C, Miller F, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Fisch M, Burger M, Fritsche HM.

Urol Int. 2014;93(3):352-60. doi: 10.1159/000362248. Epub 2014 Aug 19.


Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.

May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Fisch M, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M, Denzinger S, Stief CG, Bastian PJ, Aziz A.

Ann Surg Oncol. 2014 Nov;21(12):4034-40. doi: 10.1245/s10434-014-3827-y. Epub 2014 Jun 4.


Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.

Aziz A, Fritsche HM, Gakis G, Kluth LA, Hassan Fa, Engel O, Dahlem R, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Shariat SF, Fisch M, Burger M, Rink M.

Urol Oncol. 2014 Nov;32(8):1141-50. doi: 10.1016/j.urolonc.2014.04.008. Epub 2014 May 22.


Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.

May M, Aziz A, Brookman-May S, Roghmann F, Noldus J, Rink M, Chun F, Fisch M, Novotny V, Wirth M, Mayr R, Pycha A, Brisuda A, Volkmer B, Stredele R, Dechet C, Vallo S, Haferkamp A, Schnabel M, Denzinger S, Roigas J, Stief CG, Gilfrich C, Bastian PJ, Engel JB, Burger M, Fritsche HM.

World J Urol. 2015 Mar;33(3):343-50. doi: 10.1007/s00345-014-1308-3. Epub 2014 May 10.


Diagnostic and prognostic impact of peritumoral stromal remodeling in patients with surgically treated invasive penile squamous cell cancer.

Gunia S, Jain A, Albrecht K, Koch S, Otto W, Denzinger S, Götz S, Niessl N, Burger M, May M.

Hum Pathol. 2014 Jun;45(6):1169-76. doi: 10.1016/j.humpath.2014.01.012. Epub 2014 Jan 31.


The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder.

Gierth M, Aziz A, Fritsche HM, Burger M, Otto W, Zeman F, Pawlik MT, Hansen E, May M, Denzinger S.

World J Urol. 2014 Dec;32(6):1447-53. doi: 10.1007/s00345-014-1257-x. Epub 2014 Feb 8.


Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.

Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F; PROMETRICS 2011 research group.

Eur Urol. 2014 Jul;66(1):156-63. doi: 10.1016/j.eururo.2013.12.018. Epub 2013 Dec 27.


Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.

Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E.

Carcinogenesis. 2014 Mar;35(3):727-36. doi: 10.1093/carcin/bgt375. Epub 2013 Nov 21.


Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.

Rubenwolf PC, Otto W, Denzinger S, Hofstädter F, Wieland W, Georgopoulos NT.

World J Urol. 2014 Aug;32(4):991-7.


Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients.

Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F.

Clin Genitourin Cancer. 2013 Dec;11(4):537-44. doi: 10.1016/j.clgc.2013.05.001. Epub 2013 Jul 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk